Top Regulatory News Stories – Week Ending September 22, 2017

This week the FDA approved two new molecular entities and the EC approved four new programs. Several new orphan drug designations were granted along with a fast track designation.  Here are the top regulatory news stories this week: Bayer received FDA Approval for Aliqopa™ (copanlisib) 60 mg vial for Injection in adults with Relapsed Follicular[…]